Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Conditions: Systemic Sclerosis With Lung Involvement; Systemic Sclerosis; Interstitial Lung Disease Interventions: Drug: Mycophenolate Mofetil; Other: Placebo Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); McGill University; University of Calgary; St. Joseph's Healthcare Hamilton; Jewish General Hospital; Canadian Institutes of Health Research (CIHR); Sclérodermie Québec Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials